Monday, April 1, 2024

Your Birthday Scratcher Awaits...

Cheers! We're Officially 22 years old ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­

Petrodollar Cracks: Saudi Arabia Wants Yuan

Putin loves it...........................................................................................

Unsubscribe

Dear Reader,

The death of the "petrodollar" seems imminent.

And the implications could not be worse for Americans.

Russia, China and India have decided to abandon the petrodollar.

For one main reason.

To get around the energy sanctions on Russian oil and gas.

Nations forming a sort of BRICS (Brazil, Russia, India, China, and South Africa) alliance have banded together to conduct trade among themselves in their own currencies.

More recently, Saudi Arabia — one of the original OPEC cartel nations — has joined the BRICS nations as well.

The rumor mill expects the already weak US dollar to potentially collapse.

Which means every dollar you hold in a retirement account could instantly drop in value.

In answer to this issue, we have released a Special Report to the public.

Within its pages, you will discover how to protect your retirement savings before this developing situation impacts your money.

For a free copy…

Click here.

email-img
Regards,

Paul Stone
CEO, Colonial Metals Group


This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above.

Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe .

StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS

StockEarnings.com



Today's Bonus Content: The Gold Grab of the Century!

Your bank is lying to you.

We Value Your Thoughts + A Little Surprise for You 🎁

Hi ,

We're on a mission to bring new and exciting offerings to our store. But to do this, we need a sprinkle of your magic – your opinion!

Take the 8-question survey here.

It won't take long, and your insights will directly influence our future offerings. Plus, there's a special thank you waiting for you at the end.

Thank you! 

 

 

 

 

 

 

 

Take the 8-question survey here.

P.S. Don't forget, there's a special gift waiting for you at the end of the survey. Cheers to that!



You received this email from Wine by Lamborghini. If you would like to unsubscribe, click here.

Navy Allows Boot Camp Recruits to Use Personal Cell Phones to Make Calls to Family at Home

Military.com
Daily Brief
01 April 2024
Navy Allows Boot Camp Recruits to Use Personal Cell Phones to Make Calls to Family at Home
The Navy said beginning Friday it's allowing boot camp recruits to use their cell phones for family calls after a small test of the new policy rolled out in late November.
Read More
More Military.com Stories
The Army Has Finally Fielded Its Next Generation Squad Weapons
After 2023 Barracks Vandalism, Soldier at Fort Cavazos Faces Charges of Arson, Property Damage, Child Porn
More Specialty Drugs Cost Less with New Pharmacy's Addition to Tricare Home Delivery
The VA and DoD Don't Have a Funding Problem. They Have a Mismanagement Crisis. (Opinion)
Military.com Values Your Feedback. Take Our Quick Survey
Louis Gossett Jr., Award-Winning Actor Who Portrayed Hard-Nosed Marine in 'An Officer and a Gentleman,' Has Died at 87
Israeli Troops Withdraw from Shifa Hospital, Gaza's Largest, After 2-Week Raid
Report: 'Adversary' Responsible for Havana Syndrome Attacks
Moscow Terror Attack Showed Growing Reach of ISIS-K – Could the US Be Next?
Newly Renovated Vietnam Veterans Memorial Replica Dedicated in Georgia
US Coast Guard Ship Named for World War II Hero Commissioned in New London
The US Welcomes the New Palestinian Government Following its Repeated Calls for Political Reform
Hezbollah Fires Heavy Rockets at Northern Israel After Deadliest Day of Israeli Strikes on Lebanon
3 UN Military Observers, a Lebanese Interpreter Wounded in Blast While Patrolling Southern Border
As Conflict Worsens in Eastern Congo, 2 Armed Groups Pledge to Respect Civilians
France Asks for Foreign Police and Military Help with Massive Paris Olympics Security Challenge
Service Members and Recruits Share Their Favorite Military Fitness Workouts
Today's Military Trivia
Morgan Freeman served in what branch of the military from 1955-59, before pursuing an acting career?
Video of the Day
Young Football Players and Residents in Kyiv React After Ukraine Qualifies for Euro 2024
Watch More Military.com Videos
Download our Military News App!
App Store Google Play
You are subscribed to the Early Brief.
Unsubscribe   |   Change Subscriber Options   |   Privacy Policy
Military.com     Military.com     Military.com     Military.com     Military.com
Reach millions of people in the military community. Advertise with us
Copyright © 2024 Military Advantage, Inc. All rights reserved.
133 Boston Post Road, Weston, MA 02493

Last chance (clock is ticking, no fooling.)

Today Is The Big Day!

In just a few hours I'm co-hosting a live webinar that reveals the results of an unusual trading experiment. Go here to register right now. (It's free.)

And I’m even sharing a free trade idea with everyone that joins the webinar!

Time is short but here's what you need to know:

I sat down with a little-known trading outfit based out of Texas with decades of experience when it comes to creating trading algorithms. They've coded strategies for multi-billion dollar hedge funds and in fact one of their "trading algos" generated an incredible $4.6 million in just a month.

The point of this experiment was to let this company essentially "map my brain" and create a powerful new trading system based on the decades of wisdom locked inside my head.

The early results are nothing short of stunning. Take a look at these profit opportunities...

  • A 38% gain on AAPL in just 4 days
  • A 250% gain on AMD in just over 2 weeks
  • 124% winner on JPM in about 3 weeks
  • An incredible 305% winner on NVDA in less than 2 weeks
  • And a heart-stopping 1,601% gain on SMCI in less than a month!
  • Now of course not all trades are winners and past trading results can’t promise future success as trading incurs risk of loss.

    But I want you to be among the first to have the opportunity to put this powerful new trading tool to the test. So let me introduce you to...

    Today's Free Webinar Reveals How To Spot Profit Opportunities With Double Or Even Triple-Digit Profit Potential Up To 72 Hours Before They Happen

    Click the link above to get started.

    To your success,
    Chuck Hughes
    Chuck Hughes

     
    TradeWins Logo

    © 2024 TradeWins.com. All Rights Reserved. Privacy Policy | Disclaimer | Terms and Conditions | Contact Us

    DISCLAIMER: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by Legacy Publishing LLC. For additional information on auto-trading, you may visit the SEC's website: All About Auto-Trading. The information provided by the Legacy Publishing LLC ("Legacy") Trading Services, newsletters and educational publications ("Services") is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by Legacy a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. Past performance is not necessarily indicative of future results. Please note that results may not be typical and can vary from person to person. There are inherent risks involved with investing in the stock and options market, including the loss of your investment. Any investment is at your own risk. You should only trade or invest your "risk capital" - money you can afford to lose.


    If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
    TradeWins Publishing, 528 North Country Rd., St. James, NY 11780

    OTC Morphine, APPROVED

    US Market Approval - No side effects or Addiction Risk

    Unsubscribe

    SPONSORED
    Hi,

    By now, you have heard the news rumblings.

    After 10 years of testing, Conolidine "Nature's Morphine" is APPROVED to come to the US market effective immediately.  

    As you now know, Conolidine is the most powerful natural pain reliever in the world, boasting pharmaceutical level relief with no negative effects. 

    Remember this Harvard headline?

    This is just one of MANY now online.

     

    >>> Go here to learn how Conolidine eases daily pain without side effects or addiction risk

    Imagine a relief compound 20X the power of CBD.

    Imagine lowering your pain levels by 80% or 90% without any drugs or life changes.

    .... And at 1/10th the cost of dangerous "pain management"

    As of today you can access all of this without a script or even a doctor's visit. 

    >>>
    All you have to do is visit this page to access the first Conoldine formula publicly available

    If you hurt daily you could be minutes away from a lifetime of relief. 

    To confirm, Conolidine is certified drug-free and legal to use in the US and all over the world.

    You can even travel with it.

    >>>
    All you have to do is visit this exclusive page dedicated to Conolidine

    Clint Winters, Medical Scientist

    P.S. One last bit of info, this powerful ingredient has gone through five years of clinical testing showing a 92% relief success rate. 

    >>>
    You can view the stunning results here

    P.P.S. Final thought - Big Pharma is not happy about this newly public information, they could try to censor this page at any time.
     
    This ad is sent on behalf of GDR Labs.
    1360 Union Hill Rd, Alpharetta, GA, 30004.
    If you would like to unsubscribe from receiving offers from us, please click here.
     







     
     
      This email was sent to stevenmagallanes520.nims@blogger.com by editor@dailymarketalerts.com

    DailyMarketAlerts c/o CLM Media LLC, 315 Ridgedale Avenue, #556, East Hanover, NJ 07936 United States
     
     

    Page List

    Blog Archive

    Search This Blog

    Welcome! Your 6 Most Active Stocks Report Has Arrived!...

    Welcome Hi there! Thanks for requesting your report and welcome! Keep an eye on your inbox for important updates!‌ ‌ ‌...